Joseph Talamo Receives Stock Award at Intensity Therapeutics Inc (INTS) — SEC Form 4, Jul 02, 2025

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Joseph Talamo

CFO

TXN 2025-06-30 · FILED 2025-07-02

Equity Position 14.2K sh 0 → 14,179

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Intensity Therapeutics Inc

INTS CIK 0001567264

Reporting Owner

Name	Relationship
Joseph Talamo CIK 0001524547	CFO

Joseph Talamo at Intensity Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Intensity Therapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common Stock, $0.0001 Par ValueF1 F2	2025-06-30	A - Award/Grant	14,179 A	$0.26	+$3,701	14,179	Direct

Footnotes (2)

F1: The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2024 Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). Show more
F2: In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2025. Show more

Other insiders at Intensity Therapeutics Inc

GET /v1/forms/4/0001567264-25-000065 API docs